Loading BSD 13F portfolios...
Elite Manager Tracking
The Top 150 BSDs
Real-time 13F holding analysis for the industry's most influential institutional investors. Track conviction shifts, new entries, and structural exits.
Real-time 13F holding analysis for the industry's most influential institutional investors. Track conviction shifts, new entries, and structural exits.
Institutional Investor • RTW Investments
Value
$0M
Stocks
50 Stocks (1 new)
Turnover
0.0%
Top Holdings
KLRA(95.56%) MDGL(0.43%) ARGX(0.26%) PTCT(0.25%) PTGX(0.25%)
Investment philosophy details pending verification.
| Ticker | P/C | Company Name | Sector | Market Value | Shares | Weight | Chg Shares | % Chg |
|---|---|---|---|---|---|---|---|---|
| KLRA | None | KLRA | General | $237413.3M | 0 | 95.6% | 0 | +100.0% |
| MDGL | None | Madrigal | Health Care | $1070.5M | 0 | 0.4% | 0 | No Change |
| ARGX | None | Argenx Se | Health Care | $658.2M | 0 | 0.3% | 0 | No Change |
| PTCT | None | PTC Therapeutics, Inc. | General | $631.9M | 0 | 0.3% | 0 | No Change |
| PTGX | None | Protagonist Therapeutics, Inc. | Health Care | $620.4M | 0 | 0.3% | 0 | No Change |
| CGON | None | CG Oncology, Inc. | Healthcare | $605.0M | 0 | 0.2% | 0 | No Change |
| INSM | None | Insmed Incorporated | Health Care | $516.3M | 0 | 0.2% | 0 | No Change |
| TNGX | None | Tango Therapeutics | General | $434.5M | 0 | 0.2% | 0 | No Change |
| SYRE | None | SPYRE THERAPEUTICS INC | General | $377.5M | 0 | 0.1% | 0 | No Change |
| CELC | None | Celcuity Inc. | Health Care | $345.8M | 0 | 0.1% | 0 | No Change |
| Ticker | Amount | % Chg | Weight | Status |
|---|---|---|---|---|
| KLRAKLRA | $237413.3M | +100.0% | 95.6% | New |
| Ticker | Amount | % Chg | Weight | Status |
|---|---|---|---|---|
| No recent sells. | ||||
| Sector | Stocks | Value | Exposure |
|---|---|---|---|
| General | 28 | $241659.3M | 97.3% |
| Health Care | 18 | $5620.4M | 2.3% |
| Healthcare | 3 | $1016.0M | 0.4% |
| Industrials | 1 | $159.5M | 0.1% |